Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amgen Inc.
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Biotech
Market Cap: $148.96B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.36 | 0.99%
Avg Daily Range (30 D): $3.97 | 1.35%
Avg Daily Range (90 D): $3.46 | 1.19%
Institutional Daily Volume
Avg Daily Volume: 4.86M
Avg Daily Volume (30 D): 2.3M
Avg Daily Volume (90 D): 2.38M
Trade Size
Avg Trade Size (Sh.): 135
Avg Trade Size (Sh.) (30 D): 40
Avg Trade Size (Sh.) (90 D): 43
Institutional Trades
Total Inst.Trades: 112,634
Avg Inst. Trade: $6.13M
Avg Inst. Trade (30 D): $39.69M
Avg Inst. Trade (90 D): $33.89M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 20
Market Closing Trades
Avg Closing Trade: $63.74M
Avg Closing Trade (30 D): $201.77M
Avg Closing Trade (90 D): $181.95M
Avg Closing Volume: 385.93K
       
News
Apr 22, 2025 @ 9:37 PM
Why Vertex Pharmaceuticals Was Such a Healthy Stoc...
Source: Eric Volkman
Apr 22, 2025 @ 1:53 PM
3 Relatively Safe Healthcare Growth Stocks You Can...
Source: The Motley Fool
Apr 14, 2025 @ 2:00 PM
[Corrected] Sandoz files antitrust litigation agai...
Source: N/A
Apr 10, 2025 @ 9:59 AM
Biopharmaceuticals Global Overview Report 2025: Gl...
Source: Researchandmarkets.Com
Apr 8, 2025 @ 8:48 AM
Minimal Residual Disease Testing Market Forecast R...
Source: Researchandmarkets.Com
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $7.89 $5.27 $1.39
Diluted EPS $7.82 $5.22 $1.38
Revenue $ 32.53B $ 8.5B $ 8.39B
Gross Profit $ 19.68B $ 5.19B $ 5.15B
Net Income / Loss $ 4.23B $ 2.83B $ 746M
Operating Income / Loss $ 6.22B $ 2.05B $ 1.91B
Cost of Revenue $ 12.86B $ 3.31B $ 3.24B
Net Cash Flow $ -25730M $ -290M $ -407M
PE Ratio 35.97